Institutional investor American Trust sold 835 Medtronic shares, reducing stake by 7.7%.
Institutional investor American Trust reduced Medtronic Plc's stake by 7.7%, holding 10,028 shares after selling 835 shares in Q1. Medtronic reported $8.59bn revenue and $1.46 EPS, surpassing analyst expectations. The company has a market cap of $104.52bn, P/E ratio of 29.64, and a dividend payout ratio of 101.82%. Several brokerages have a "Hold" rating on MDT, with a consensus price target of $90.90.
August 03, 2024
3 Articles